Dr Euphemia Leung

Research | Current

Research interests

Research group

Selected publications and creative works (Research Outputs)

  • Hanif, M., Arshad, J., Astin, J. W., Rana, Z., Zafar, A., Movassaghi, S., ... Reynisson, J. (2020). A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor. Angewandte Chemie, 132 (34), 14717-14722. 10.1002/ange.202005758
    Other University of Auckland co-authors: Tilo Söhnel, Muhammad Hanif, Jonathan Astin, Stephen Jamieson, Christian Hartinger
  • Chang, Y.-C., Kondapuram, S. K., Yang, T.-H., Syed, S. B., Cheng, S. M., Lin, T.-Y., ... Leung, E. (2020). The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells. Toxicology and applied pharmacology, 40110.1016/j.taap.2020.115080
  • Lin, T.-Y., Chan, H.-H., Chen, S.-H., Sarvagalla, S., Chen, P.-S., Coumar, M. S., ... Leung, E. (2020). BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells. Autophagy, 16 (7), 1296-1313. 10.1080/15548627.2019.1671643
  • Singleton, D. C., Dechaume, A.-L., Murray, P. M., Katt, W. P., Baguley, B. C., & Leung, E. Y. (2020). Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer. BMC cancer, 20 (1)10.1186/s12885-020-06885-3
    Other University of Auckland co-authors: Dean Singleton
  • Ameratunga, R., Lehnert, K., Leung, E., Comoletti, D., Snell, R., Woon, S.-T., ... McKee, J. (2020). Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection. The New Zealand medical journal, 133 (1515), 112-118.
    Other University of Auckland co-authors: Klaus Lehnert, Helen Petousis-Harris, Russell Snell
  • Hanif, M., Arshad, J., Astin, J. W., Rana, Z., Zafar, A., Movassaghi, S., ... Reynisson, J. (2020). A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor. Angewandte Chemie (International ed. in English)10.1002/anie.202005758
    Other University of Auckland co-authors: Tilo Söhnel, Christian Hartinger, Muhammad Hanif, Stephen Jamieson
  • Ferraro-Peyret, C., Askarian-Amiri, M. E., Sarkar, D., Joseph, W. R., Hansji, H., Baguley, B. C., & Leung, E. Y. (2020). SOX2OT Long Noncoding RNA Is Regulated by the UPR in Oestrogen Receptor-Positive Breast Cancer. Sci, 2 (24)10.3390/sci2020024
    Other University of Auckland co-authors: Wayne Joseph
  • Pilkington, L. I., Sparrow, K., Rees, S. W. P., Paulin, E. K., van Rensburg, M., Xu, C. S., ... Leung, E. (2020). Development, synthesis and biological investigation of a novel class of potent PC-PLC inhibitors. European journal of medicinal chemistry, 19110.1016/j.ejmech.2020.112162
    Other University of Auckland co-authors: Ivanhoe Leung, Lisa Pilkington, Shaun Rees, Emily Paulin, Ries Langley, David Barker

Identifiers

Contact details

Primary office location

M&HS BUILDING 504 - Bldg 504
Level 0, Room 002
85 PARK RD
GRAFTON
AUCKLAND 1023
New Zealand

Web links